<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04270331</url>
  </required_header>
  <id_info>
    <org_study_id>MURA2020/151</org_study_id>
    <nct_id>NCT04270331</nct_id>
  </id_info>
  <brief_title>Assessment and Management of Pain, Agitation, Delirium and Sleep Deprivation (PADS) in ICU by PADS Protocol, Thailand</brief_title>
  <official_title>Pain, Agitation, Delirium and Sleep Deprivation Assessment and Management in Intensive Care Units, Thailand: a Before-after Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators proposed that pain, agitation, delirium and sleep deprivation protocol
      (PADS) will help improve the patients' outcomes (shortening ICU length of stay, improving
      ventilator free days, increasing delirium free days) in critically ill patients, a university
      hospital, Thailand.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain is frequently reported in patients admitted to an ICU, with an incidence of up to 50% in
      medical patients during admission, and increasing up to 80% during standard care procedures.
      Agitation was also reported in 52% of the patients, typically within 4-9 days after
      admission. However, there were studies reporting inadequate pain, agitation and delirium
      assessment and management in real-world clinical practice. The clinical practice guideline
      for the management of pain, agitation/sedation, delirium, immobility, and sleep disruption in
      adult patients in the ICU was recently published in 2018 and emphasized routinely monitoring
      pain, agitation and delirium during ICU admissions. Also, appropriate management of pain and
      agitation in critically ill patients resulted in reduction in ICU length of stay, hospital
      length of stay, delirium and mortality. Therefore, structural pain, agitation/sedation,
      delirium assessment and treatment in the ICUs, Thailand might be necessary.

      Since pain, agitation/sedation and delirium protocol has not yet been initiated in ICUs,
      Thailand, this study is designed as a before-after study in order to assess outcomes by
      comparing between before and after protocol initiation. The objectives of the study were to
      document the impact of pain, agitation/sedation, delirium protocol on clinical outcomes of
      ICU patients admitted to ICUs at Ramathibodi Hospital, a university hospital, Thailand
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>A before-after study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ICU free days</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Days alive and not stay in ICU</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilator free days</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Day alive and free of mechanical ventilator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium free days</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Day alive and free of delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of pain, agitation/sedation, delirium, sleep deprivation assessement</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Times per patient-days of evaluations during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of in-target pain, agitation/sedation, delirium</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Times per patient-days of in-target pain, agitation/sedation, delirium during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance to PADS protocol</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Times per patient-days of PADS protocol use by healthcare providers during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause hospital mortality</measure>
    <time_frame>During hospital stay or death or a maximum of 90 days</time_frame>
    <description>Rates of all-cause mortality during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Antipsychotics use</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Type and dose of antipsychotics during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-benzodiazepines use</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Type and dose of non-benzodiazepines during ICU stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Benzodiazepines use</measure>
    <time_frame>During ICU stay or death or a maximum of 28 days</time_frame>
    <description>Type and dose of non-benzodiazepines during ICU stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Pain</condition>
  <condition>Agitation on Recovery From Sedation</condition>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>A Before group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No protocol assigned</description>
  </arm_group>
  <arm_group>
    <arm_group_label>An After group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PADS (pain, agitation, delirium, sleep deprivation assessment and management) protocol assigned</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PADS protocol</intervention_name>
    <description>Assessment and management per PADS protocol</description>
    <arm_group_label>An After group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (18 years and older)

          -  Patients admitted to medical or surgical intensive care units

        Exclusion Criteria:

          -  Terminal ill patients, or patients unlikely to survive &gt; 24 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Punchika Luetrakool, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ramathibodi hospital, Mahidol university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pitchaya Dilokpattanamongkol, BCPS, BCCCP</last_name>
    <phone>662 644 8694</phone>
    <email>pitchaya.dil@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Punchika Luetrakool, MD</last_name>
    <email>punchi0906@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B, Balas MC, van den Boogaard M, Bosma KJ, Brummel NE, Chanques G, Denehy L, Drouot X, Fraser GL, Harris JE, Joffe AM, Kho ME, Kress JP, Lanphere JA, McKinley S, Neufeld KJ, Pisani MA, Payen JF, Pun BT, Puntillo KA, Riker RR, Robinson BRH, Shehabi Y, Szumita PM, Winkelman C, Centofanti JE, Price C, Nikayin S, Misak CJ, Flood PD, Kiedrowski K, Alhazzani W. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018 Sep;46(9):e825-e873. doi: 10.1097/CCM.0000000000003299.</citation>
    <PMID>30113379</PMID>
  </reference>
  <reference>
    <citation>Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013 Jan;41(1):263-306. doi: 10.1097/CCM.0b013e3182783b72. Review.</citation>
    <PMID>23269131</PMID>
  </reference>
  <reference>
    <citation>Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014 Jan 30;370(5):444-54. doi: 10.1056/NEJMra1208705. Review.</citation>
    <PMID>24476433</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 12, 2020</study_first_submitted>
  <study_first_submitted_qc>February 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>March 10, 2020</last_update_submitted>
  <last_update_submitted_qc>March 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Pitchaya Dilokpattanamongkol</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>agitation</keyword>
  <keyword>sedation</keyword>
  <keyword>delirium</keyword>
  <keyword>protocol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Sleep Deprivation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Plan to share individual participant data per request and after 2 years from publications</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Two years after publications</ipd_time_frame>
    <ipd_access_criteria>Per request to researchers via email</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

